Arsov C - Search Results

1

A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trial.

Arsov C, Albers P, Herkommer K, Gschwend J, Imkamp F, Peters I, Kuczyk M, Hadaschik B, Kristiansen G, Schimmöller L, Antoch G, Rummeny E, Wacker F, Schlemmer H, Benner A, Siener R, Kaaks R, Becker N. Arsov C, et al. Int J Cancer. 2022 Jun 1;150(11):1861-1869. doi: 10.1002/ijc.33940. Epub 2022 Feb 17. Int J Cancer. 2022. PMID: 35076933 Clinical Trial.

2

[Prostate cancer centres / prostate centres--certified by DKG or DVPZ].

Arsov C, Albers P. Arsov C, et al. Aktuelle Urol. 2009 Mar;40(2):87-90. doi: 10.1055/s-0028-1098851. Epub 2009 Mar 18. Aktuelle Urol. 2009. PMID: 19296423 German.

3

[Value of galvanotherapy for localised prostate cancer].

Arsov C, Winter C, Albers P. Arsov C, et al. Urologe A. 2009 Jul;48(7):748-54. doi: 10.1007/s00120-009-1986-4. Urologe A. 2009. PMID: 19517089 Review. German.

4

Extraperitoneal laparo-endoscopic single-site radical prostatectomy: first experience.

Rabenalt R, Arsov C, Giessing M, Winter C, Albers P. Rabenalt R, et al. Among authors: arsov c. World J Urol. 2010 Dec;28(6):705-8. doi: 10.1007/s00345-010-0534-6. Epub 2010 Mar 27. World J Urol. 2010. PMID: 20349073

5

Current second-line treatment options for patients with castration resistant prostate cancer (CRPC) resistant to docetaxel.

Arsov C, Winter C, Rabenalt R, Albers P. Arsov C, et al. Urol Oncol. 2012 Nov-Dec;30(6):762-71. doi: 10.1016/j.urolonc.2010.02.001. Epub 2010 Sep 29. Urol Oncol. 2012. PMID: 20884252 Review.

6

Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot study.

Arsov C, Quentin M, Rabenalt R, Antoch G, Albers P, Blondin D. Arsov C, et al. Anticancer Res. 2012 Mar;32(3):1087-92. Anticancer Res. 2012. PMID: 22399637

7

[Standardised scoring of a multi-parametric 3-T MRI for a targeted MRI-guided prostate biopsy].

Arsov C, Blondin D, Rabenalt R, Antoch G, Albers P, Quentin M. Arsov C, et al. Urologe A. 2012 Jun;51(6):848-56. doi: 10.1007/s00120-012-2825-6. Urologe A. 2012. PMID: 22476739 German.

8

Evaluation of a structured report of functional prostate magnetic resonance imaging in patients with suspicion for prostate cancer or under active surveillance.

Quentin M, Blondin D, Klasen J, Schek J, Buchbender C, Miese FR, Antoch G, Barski D, Albers P, Arsov C. Quentin M, et al. Among authors: arsov c. Urol Int. 2012;89(1):25-9. doi: 10.1159/000338808. Epub 2012 Jun 7. Urol Int. 2012. PMID: 22677880

9

Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.

Quentin M, Arsov C, Röhlen S, Klasen J, Antoch G, Albers P, Blondin D. Quentin M, et al. Among authors: arsov c. Rofo. 2012 Oct;184(10):925-9. doi: 10.1055/s-0032-1312876. Epub 2012 Jun 28. Rofo. 2012. PMID: 22744328

10

Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients.

Barski D, Richter M, Winter C, Arsov C, de Geeter P, Rabenalt R, Albers P. Barski D, et al. Among authors: arsov c. World J Urol. 2013 Oct;31(5):1253-9. doi: 10.1007/s00345-012-0901-6. Epub 2012 Jul 11. World J Urol. 2013. PMID: 22782618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters